The E. coli derived protein contains the full-length sequence of N-terminal epitopes of HIV-I gp41 395 amino acids (444-833) immunodominant regions gp41L. The protein is fused to b-galactosidase (114 kDa) at N-Terminus.
Formulation: 8M Urea, 20mM Tris-HCl pH 8.0, 10mM beta-mercaptoethanol.
Physical Appearance: Sterile filtered colorless clear solution.
Purity: Greater than 95% as determined by HPLC analysis & SDS-PAGE.
Source:Escherichia coli.
Amino acid sequence: IEFPGIFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRVVQ
REKRAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSGIVQQQNNLLR AIEAQQHLLQLTVW
GIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNNMTWMEWDRE
INNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAV
LSVVNRVRQGYSPLSFQTHLPIPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSY
HRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQ
GAYRAIRHIPRRIRQGLERILL.
Stability: HIV-1 gp41 Long although stable at +4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles.
Transportation method: Shipped with Ice Packs.
Specificity: Immunoreactive with all sera of HIV-1 infected individuals.
Safety data sheet: Inquire at info@3hbiomedical.com